• Treatment With VBI-1901 Linked to Tumor Stabilization in Recurrent Gliobastoma Patients in Phase 1/2 Trial
  • CytomX Initiates Phase 2 Trial Testing CX-072, Yervoy Combo in Relapsed or Refractory Melanoma
  • 2 Imfinzi Combos Delay Cancer Progression in Metastatic NSCLC, Interim Phase 3 Data Show
  • MDNA55 Increases Survival in Glioblastoma, Notably in Patients With High ILR4 Levels, Early Trial Data Show
  • Opdivo-Yervoy Plus Shorter Chemotherapy Course Extends Survival of Patients with Advanced Lung Cancer, Early Trial Data Show
  • Tecentriq-Avastin Prolongs Life of Patients with Advanced Liver Cancer in Trial, Roche Reports
  • European Commission Approves Bavencio-Inlyta for First-line Treatment of Advanced Kidney Cancer
  • Keytruda Survival Benefits Similar to Chemo for Relapsed Mesothelioma, Phase 3 Trial Finds
  • Blincyto Increases Survival of ALL Children, Adolescents After First Relapse, Phase 3 Trials Show
  • CHMP Favors Keytruda Regimens to Treat Recurrent Head and Neck Cancers
  • Imfinzi Lessens Cancer Spread, Explaining Extended Survival in NSCLC Patients, Phase 3 Data Show
  • First Patients Dosed in Phase 1/2 Trial Testing Galinpepimut-S, Keytruda Combo in Advanced Cancers